Capital · deployed
~$1.1B capex + ~$2.6B buybacks committed FY25; near-zero M&A (~$88M) — capital held back during the margin shock
Sourced figures 1
- stockanalysis.com ELV financials + cash-flow statement capex $1,116M FY25; share repurchases $2,605M FY25; cash acquisitions $88M FY25
the working
Threads 1
A claim is one metric we assert about a node — the value is the summary, this page is the receipt. Sourced from kestrel; supersedes-history not yet shown. Back to Elevance Health.